Why it earned this rating
Our assessment
AccumulatorPlus 7 is a competent accumulation FIA with a deeper-than-average index menu and meaningful waiver provisions built in at no additional charge. It earns a Good Option rating because those features are genuine, but the product is held back by the absence of an income rider option, a 9%/9% front-loaded surrender schedule that is steeper than many 7-year peers, and the fact that current cap rates and participation rates were flagged as low-confidence in the available materials.
The short version
This is a 7-year principal-protected annuity for accumulation-focused buyers who want more index exposure choices than a basic FIA typically offers. The contract adds something most accumulation FIAs do not include at no cost: waiver protection for nursing home, terminal illness, and home health care events. What you do not get here is any income rider option. If guaranteed lifetime income is the goal, this is the wrong product.
Key facts
The full review
Is F&G AccumulatorPlus 7 a Good Annuity?
It depends on what you need. For someone focused on accumulation with principal protection, a broad crediting menu, and a 7-year time horizon, this is a reasonable product. For someone who wants guaranteed lifetime income or expects to need the money within a few years, it is not the right fit. The built-in waiver provisions for care events are a genuine differentiator that adds real value for buyers in their 60s and 70s.
Why Someone Would Buy This Annuity
The rational case is straightforward: principal protection, index-linked upside potential across multiple strategies, and built-in access to some liquidity in the event of a nursing home stay or terminal diagnosis — all without a separate rider fee. The $10,000 minimum premium also makes it accessible to buyers who cannot meet the $25,000 or higher minimums on some competitor products. Buyers who want to spread across multiple index strategies inside a single contract will find more options here than in a simpler FIA design.
Who This Annuity Is Best For
I think AccumulatorPlus 7 is best suited for pre-retirees or early retirees in their late 50s to mid-70s who want a 7-year accumulation vehicle, have no near-term need for systematic lifetime income, and appreciate having waiver coverage for care-related events already included. It works well for both qualified and non-qualified money, given the wide issue age range. It is less attractive for anyone whose primary goal is generating a guaranteed income stream, or for anyone who may need to access more than the free-withdrawal amount before the surrender period ends.
What You're Really Buying Here
You are not investing in the stock market. You are buying an insurance contract that uses several different index-linked formulas to determine how much interest may be credited each year, while protecting the account value from direct index losses. F&G keeps the money in its general account and uses options strategies to deliver the index-linked return. If an index finishes flat or down, you typically credit zero interest rather than losing account value. That principal floor is the core promise. The index participation — however much or little you actually capture — is the upside story layered on top.
How the Core Feature Works
AccumulatorPlus 7 offers six crediting methods across four indices. The methods include Annual Point-to-Point (with a cap or participation rate), Biennial Point-to-Point (measured over two years), Monthly Averaging, Monthly Point-to-Point, Performance Triggered, and a Fixed rate option. The indices available include the S&P 500, GS Global Factor Index, Morgan Stanley US Equity Allocator Index, and Barclays Trailblazer Sectors 5 Index.
A few things to understand about this menu: Annual Point-to-Point is the simplest — it compares the index value at the start and end of the year and credits interest up to a cap or at a participation rate. Biennial Point-to-Point extends that to a two-year measurement, which can sometimes allow for higher caps. Monthly Averaging smooths out volatility by averaging end-of-month values, which can help in choppy markets but may underperform in a straight-up year. Monthly Point-to-Point with a monthly cap is more complex and can lag in trending markets. Performance Triggered credits a fixed rate when the index is flat or positive, regardless of how much it gains — that rate is predetermined and the structure suits buyers who want a steady credit in positive-return environments.
The specialty indices — GS Global Factor, Morgan Stanley US Equity Allocator, and Barclays Trailblazer Sectors 5 — are strategy indices with built-in volatility controls. They tend to move more slowly than the S&P 500, which typically allows for higher participation rates but also means they will not capture the same gains in a strong equity year. Some of the optional crediting strategies carry a 1.25% annual fee in exchange for higher participation rates. Whether that trade is worth it depends on how the index performs — and that is impossible to know in advance.
Note: the specific cap rates, participation rates, and spreads available at time of application were low-confidence in the source materials. Ask F&G or your agent for the current rate sheet before making any allocation decisions.
Why the Secondary Feature Matters
The built-in waiver provisions are the secondary feature worth discussing. AccumulatorPlus 7 includes surrender charge waivers for nursing home confinement, home health care, terminal illness, and death — at no additional fee. This matters because care events often force people to liquidate assets at the worst time. Having that protection baked into an accumulation FIA rather than requiring a separate rider purchase makes the product meaningfully more flexible for buyers who are realistic about the possibility of a health event during a 7-year commitment. It is not a long-term care replacement, but it does give the contract a layer of access that a plain accumulation FIA typically does not include.
Liquidity and Surrender Schedule
AccumulatorPlus 7 allows free withdrawals of up to 10% of account value after year one. That is a standard FIA provision. What is less standard is the opening surrender schedule: 9% in both year one and year two, stepping down to 8%, 7%, 6%, 5%, and 4% through year seven, then going to zero.
A 9% charge in the first two years is at the steeper end of what 7-year FIAs typically charge. Many 7-year peers open at 7% or 8%. That means if something changes in the first couple of years and you need to exit, the cost is higher here than on some alternatives. A market value adjustment — MVA — also applies during the surrender period. The MVA can increase or decrease the effective surrender cost depending on where interest rates have moved since issue. In a rising-rate environment, the MVA can meaningfully add to the exit cost; in a falling-rate environment it works in your favor. Systematic withdrawals are allowed on a monthly, quarterly, or semi-annual basis, and up to four non-systematic withdrawals per year are permitted. RMDs are not subject to surrender charges.
| Contract Year | Surrender Charge |
|---|---|
| 1 | 9% |
| 2 | 9% |
| 3 | 8% |
| 4 | 7% |
| 5 | 6% |
| 6 | 5% |
| 7 | 4% |
| 8 | 0% |
Fees and Tradeoffs
The base contract has no explicit annual fee. The only fee in the product is the optional 1.25% annual charge on certain crediting strategies — specifically the ones that use higher participation rates in exchange for that cost. That fee is deducted from the account value at the beginning of the crediting period if you choose those strategies. It is optional, and buyers who stick to the standard crediting options pay no annual fee beyond the implicit cost of the cap or participation structure.
The structural tradeoffs are the more important ones. You are giving up direct market participation and liquidity in exchange for the floor and the insurance wrapper. The 9%/9% front-loaded surrender charge is a meaningful risk if your plans change. The MVA is an additional variable on top of that. The specialty indices come with volatility controls that can limit performance relative to the S&P 500 in a strong year. None of these are unique to this product, but they are all real.
Product snapshot
| Feature | Details |
|---|---|
| Product Type | Fixed Indexed Annuity |
| Surrender Period | 7 years |
| Issue Ages | NQ: 0-85, Q: 18-85 |
| Minimum Premium | $10,000 |
| Indices | S&P 500, GS Global Factor Index, Morgan Stanley US Equity Allocator Index, Barclays Trailblazer Sectors 5 Index |
| Crediting Methods | Annual Point-to-Point, Biennial Point-to-Point, Monthly Averaging, Monthly Point-to-Point, Performance Triggered, Fixed |
| Free Withdrawal | 10% of account value annually after year one |
| MGSV | 87.5% of premiums at 1-3% |
| Death Benefit | Greater of full account value or minimum guaranteed surrender value, paid as lump sum |
| Income Rider | Not available |
| Premium Bonus | None |
| Availability | Available in most states except NY. Variations approved in AK, AL, CT, FL, ID, IL, MA, MN, MO, MS, MT, NH, OR, PA, TX, WA. |
Carrier snapshot
Legal Entity: Fidelity & Guaranty Life Insurance Company
Parent: FGL Holdings
A.M. Best Rating: A
F&G is a mid-tier carrier with a national distribution footprint. The A rating from A.M. Best reflects adequate financial strength for an annuity carrier of this type. F&G is not among the largest carriers in the industry, but it has a sustained presence in the indexed annuity market and AccumulatorPlus has been part of its core lineup for several years.
Final take
AccumulatorPlus 7 is a reasonable accumulation FIA for buyers who want a broad index menu, built-in waiver protections, and a $10,000 entry point. It is not the right contract for someone who wants guaranteed lifetime income — no income rider is available. It is also not the right contract for someone worried about needing early access, given the 9%/9% opening surrender charges and the MVA.
Where it earns its place is with the buyer who wants a 7-year commitment to index-linked growth, appreciates having multiple crediting strategies to choose from, and values the waiver provisions that cover care events and terminal illness at no extra cost. For that buyer, this is a good option — not exceptional, but genuinely useful.
